Prochlorperazine
پروکلرپرازین
🧠 Nervous SystemPhenothiazine antiemetic
Market / country: 🇺🇸 USA
Compazine (US)
🧮 Dose calculator
Nausea and vomiting · Regimen source: FDA Prochlorperazine · Dosage and Administration - Adults
- • Above 40 mg/day only in resistant cases. FDA Prochlorperazine · Dosage and Administration - Adults
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Do not use under 2 years or under 20 lb; not in pediatric surgery. FDA Prochlorperazine · Contraindications
- ⚠️ Boxed warning: increased mortality in elderly patients with dementia-related psychosis. FDA Prochlorperazine · Boxed Warning
Formulations
- 5 mg tablet (scored) — tablet 🇺🇸 USA FDA Prochlorperazine · How Supplied
- 10 mg tablet — tablet 🇺🇸 USA FDA Prochlorperazine · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Prochlorperazine · Precautions/Warnings – Usage in Pregnancy
“Prochlorperazine Maleate should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Prochlorperazine · Precautions/Warnings – Nursing Mothers
“Caution should be exercised when prochlorperazine is administered to a nursing woman.”
- 👶 ChildrenContraindicated
Label: contraindicated in children below a stated age. FDA Prochlorperazine · CONTRAINDICATIONS
“Do not use in pediatric patients under 2 years of age or under 20 lbs.”
- 👴 Older adultsDangerous / avoid
Label: serious warning or avoid in older adults. FDA Prochlorperazine · Boxed Warning
“Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA040268
- DailyMed (FDA label)FDA Prochlorperazine
- MedlinePlus (NIH)Prochlorperazine
- WHO ATC/DDDN05AB04
- Darooyab (Iran)Prochlorperazine
🇮🇷 Not found in Iran list Darooyab · G-1334/Prochlorperazine
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Prochlorperazine · How SuppliedFDA Prochlorperazine · Dosage and Administration - AdultsFDA Prochlorperazine · Dosage and Administration - ChildrenFDA Prochlorperazine · ContraindicationsFDA Prochlorperazine · Boxed WarningFDA Prochlorperazine · Precautions/Warnings – Usage in PregnancyFDA Prochlorperazine · Precautions/Warnings – Nursing MothersFDA Prochlorperazine · CONTRAINDICATIONSFDA Prochlorperazine · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1334/Prochlorperazine
- Clinical review⚠ Unverified